Skip to main content
Log in

Discordance in Immunohistochemical Status of Breast Cancer Post Neoadjuvant Chemotherapy

  • Letter to the Editor
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Anand AS, Velayudhan ST (2016) Discordance of estrogen & progesterone receptors after neoadjuvant chemotherapy in breast cancer—an Indian study. Indian journal of surgical oncology 7(3):316–319

    Article  PubMed  Google Scholar 

  2. Chatterjee S, Saha A, Arun I, Nayak SS, Sinha S, Agrawal S et al (2015) Correlation of clinicopathological outcomes with changes in IHC4 status after NACT in locally advanced breast cancers: do pre-NACT ER/PR status act as better prognosticators? Breast cancer 7:381–388

    PubMed  PubMed Central  Google Scholar 

  3. Agrawal S, Banswal L, Saha A, Arun I, Datta S S, Chatterjee S, Ahmed R. Progesterone receptors, pathological complete response and early outcome for locally advanced breast cancer—a single centre study. (PPLB – 01). Indian Journal of Surgical Oncology, Springer, DOI 10.1007/s13193-016-0523

  4. Van de Ven S, Smit VTHBM, Dekker TJA, Nortier JWR, Kroep JR. Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer. Cancer Treatment Reviews; 37(6): 422–30

  5. Napa Parinyanitikul, Xiudong Lei, Mariana Chavez-Mac Gregor, Elizabeth Ann Mittendorf, Jennifer Keating Litton, Wendy A. Woodward, Hong Zhang, Gabriel N. Hortobagyi, Ana M. Gonzalez-Angulo. Receptor status changes from primary to residual breast cancer after neoadjuvant chemotherapy (NCT) and analysis of survival outcomes. J Clin Oncol 31, 2013 (suppl 26; abstr 48)

  6. Cassidy JW, Caldas C, Bruna A (2015) Maintaining tumour heterogeneity in patient-derived tumour xenografts. Cancer Res 75(15):2963–2968. doi:10.1158/0008-5472.CAN-15-0727

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Sun X, Intra-tumor YQ (2015) Heterogeneity of cancer cells and its implications for cancer treatment. Acta Pharmacol Sin 36(10):1219–1227. doi:10.1038/aps.2015.92

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Jin G, Han Y, Liu C et al (2015) Evaluation of biomarker changes after administration of various neoadjuvant chemotherapies in breast cancer. International journal of clinical and experimental pathology 8(1):914–921

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sanjit Kumar Agrawal.

Ethics declarations

Source for Funding

None.

Conflict of Interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Agrawal, S.K., Chatterjee, S., Arun, I. et al. Discordance in Immunohistochemical Status of Breast Cancer Post Neoadjuvant Chemotherapy. Indian J Surg Oncol 8, 245–246 (2017). https://doi.org/10.1007/s13193-016-0606-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-016-0606-1

Keywords

Navigation